Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
FIRST LETTER AND REPLY FORM - ELECTIONS AS TO MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
Regulatory Filings Classification · 95% confidence The document is a letter from Namyue Holdings Limited to its shareholders regarding the election of means to receive future corporate communications. It explains options for receiving documents such as annual reports, interim reports, notices of meetings, circulars, and proxy forms either electronically or in printed form. The document includes a reply form for shareholders to indicate their preference. There is no actual financial data, report content, or detailed financial analysis present. The document is an announcement about how shareholders can receive future reports and communications, not the reports themselves. It is a communication related to corporate governance and shareholder communication preferences, but does not fit into categories like Annual Report, Interim Report, or Proxy Solicitation. Given its nature as an announcement about corporate communications delivery methods, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-12-29 English
ELECTIONS OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
Regulatory Filings Classification · 95% confidence The document is an announcement from Namyue Holdings Limited regarding the elections of means of receipt of corporate communications by shareholders. It details arrangements for shareholders to elect to receive future corporate communications either in printed form or electronically via the company's website. The document references compliance with Listing Rules and Companies Ordinance, and explains the process and options for shareholders. It does not contain financial data, audit information, management changes, voting results, or any report content itself. It is a regulatory announcement about communication preferences rather than a report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities for Namyue Holdings Limited for the month ended 30 November 2023. It details movements in issued shares, confirms compliance with listing rules, and provides information about share capital and securities. The document is a regulatory submission related to share capital and securities movements, not a full financial report, earnings release, or management discussion. It is not an announcement of a report publication but a regulatory filing itself. Therefore, it fits best under the category of Regulatory Filings (RNS).
2023-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings Classification · 100% confidence The document is a monthly return report for an equity issuer listed on the Hong Kong Stock Exchange, detailing movements in securities, issued shares, and confirmations related to share issuance compliance. It is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, covering the month ended 31 October 2023. The content focuses on share capital movements and confirmations rather than financial performance, management changes, or earnings. It is not an annual or interim report, nor an earnings release or investor presentation. The document is a regulatory filing reporting compliance and share movement information as required by listing rules, fitting the definition of a Regulatory Filing (RNS).
2023-11-01 English
Terms of Reference of Nomination Committee
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of Nomination Committee' for Namyue Holdings Limited. It details the formation, composition, duties, and authority of the Nomination Committee, which is a governance body within the company. There is no financial data, earnings information, or regulatory filing content. The document focuses on governance practices related to board nominations and committee operations. This matches the description of Governance Information (CGR), which covers internal rules, board structure, and governance practices. The document length is under 5,000 characters and is not an announcement of a report but the actual terms of reference document itself. Therefore, the appropriate classification is CGR with high confidence.
2023-10-30 English
Terms of Reference of Audit Committee
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of Audit Committee' for Namyue Holdings Limited. It details the formation, composition, duties, authority, and reporting procedures of the Audit Committee. It does not contain any financial statements, audit results, or financial performance data. Instead, it outlines governance and procedural rules related to audit oversight. This type of document fits the category of Governance Information (CGR), as it describes internal rules and governance practices related to the audit committee. The document length (8177 characters) is sufficient to be a full terms of reference document, not a brief announcement or certification. Therefore, the appropriate classification is CGR with high confidence.
2023-10-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.